RIERA, Ludovica
 Distribuzione geografica
Continente #
NA - Nord America 2.657
EU - Europa 2.077
AS - Asia 987
AF - Africa 80
SA - Sud America 23
OC - Oceania 12
Continente sconosciuto - Info sul continente non disponibili 2
Totale 5.838
Nazione #
US - Stati Uniti d'America 2.625
CN - Cina 524
DK - Danimarca 408
IT - Italia 383
SE - Svezia 193
DE - Germania 176
IE - Irlanda 172
UA - Ucraina 154
FR - Francia 142
JP - Giappone 121
FI - Finlandia 110
AT - Austria 97
SG - Singapore 94
KR - Corea 78
GB - Regno Unito 69
SN - Senegal 69
IN - India 41
PL - Polonia 38
TR - Turchia 27
VN - Vietnam 27
BE - Belgio 25
CA - Canada 25
ES - Italia 25
CH - Svizzera 19
RU - Federazione Russa 16
IR - Iran 14
AU - Australia 11
QA - Qatar 9
TW - Taiwan 9
BR - Brasile 8
NL - Olanda 8
CZ - Repubblica Ceca 7
HK - Hong Kong 7
TH - Thailandia 7
BY - Bielorussia 6
CL - Cile 6
EG - Egitto 6
GR - Grecia 6
IL - Israele 6
MY - Malesia 6
NO - Norvegia 6
RO - Romania 6
CO - Colombia 5
KW - Kuwait 5
PT - Portogallo 5
MX - Messico 4
PK - Pakistan 4
AR - Argentina 3
ID - Indonesia 3
DZ - Algeria 2
EU - Europa 2
HR - Croazia 2
NI - Nicaragua 2
PH - Filippine 2
SD - Sudan 2
UZ - Uzbekistan 2
EE - Estonia 1
HU - Ungheria 1
LU - Lussemburgo 1
NZ - Nuova Zelanda 1
PE - Perù 1
PR - Porto Rico 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
ZA - Sudafrica 1
Totale 5.838
Città #
Chandler 364
Beijing 335
Ann Arbor 186
Houston 179
Dublin 170
Torino 148
Wilmington 122
Fairfield 120
Ashburn 114
Jacksonville 111
Vienna 97
Nyköping 86
Villeurbanne 86
Dearborn 80
Singapore 75
Medford 72
Redwood City 62
Princeton 61
Woodbridge 53
Cambridge 39
Seattle 39
Fremont 34
Warsaw 31
Pisa 30
Tokyo 23
Dong Ket 21
Milan 21
Boardman 18
Buffalo 18
Guangzhou 18
Boston 17
Brussels 17
Rome 17
Nanjing 14
Toronto 14
Hefei 12
Shanghai 12
Turin 12
Verona 12
Pune 11
San Mateo 11
Norwalk 10
San Jose 10
Santa Clara 10
Doha 9
Hangzhou 9
Kunming 9
Los Angeles 9
New York 9
Wuhan 9
San Diego 8
Florence 7
Istanbul 7
Paris 7
Rochester 7
Tianjin 7
Zhengzhou 7
Falls Church 6
Fountain Valley 6
Hebei 6
Philadelphia 6
Alessandria 5
Barcelona 5
Chengdu 5
Detroit 5
Kuwait City 5
Lachine 5
Murcia 5
Nanchang 5
Quattordio 5
Shenyang 5
Suita 5
Washington 5
Ankara 4
Bar Harbor 4
Bologna 4
Durham 4
Grafing 4
Helsinki 4
Munich 4
Naples 4
Phoenix 4
Silver Spring 4
Taipei 4
Bangalore 3
Bangkok 3
Bucharest 3
Central District 3
Changchun 3
Changsha 3
Columbus 3
Den Haag 3
Düsseldorf 3
Frankfurt am Main 3
Halle 3
Hamburg 3
Indianapolis 3
Izmir 3
Kraków 3
London 3
Totale 3.272
Nome #
Core binding factor acute myeloid leukaemia and c-KIT mutations 387
Description of a novel Janus kinase 3 P132A mutation in acute megakaryoblastic leukemia and demonstration of previously reported Janus kinase 3 mutations in normal subjects. 327
JAK2V617F activating mutation is associated with the myeloproliferative type of chronic myelomonocytic leukaemia 325
p130Cas mediates the transforming properties of the anaplastic lymphoma kinase 243
Novel CALR somatic mutations in essential thrombocythaemia 232
Myelodysplastic syndrome with del (5q) and JAK2V617F mutation transformed to acute myeloid leukaemia with complex karyotype 221
JAK2V617F mutation and allele burden are associated with distinct clinical and morphological subtypes in patients with essential thrombocythaemia 193
Can pegylated interferon improve the outcome of polycythemia vera patients? 172
JAK2V617F, CALR, and MPL Mutations and Bone Marrow Histology in Patients with Essential Thrombocythaemia 165
A POST-REMISSION MAINTENANCE TREATMENT WITH LOW-DOSE CHEMOTHERAPY + RETINOIDS AND DIHYDROXYLATED VITAMIN D3 MAY IMPROVE THE SURVIVAL OF POOR-PROGNOSIS AML/MDS PATIENTS 147
Chronic myelomonocytic leukaemia with marked thrombocytosis and JAK2V617F mutation transformed into an acute megakaryoblastic leukaemia. 135
DROPLED DIGITAL PCR MAY HAVE A PROGNOSTIC VALUE FOR PREDICTING RELAPSE AFTER IMATINIB DISCONTINUATION 128
EFFECT ON CLINICAL OUTCOME OF BONE MARROW RETICULIN FIBROSIS IN 579 PATIENTS WITH POLYCYTHEMIA VERA AND ESSENTIAL THROMBOCYTHEMIA 123
Retrospective analysis of 260 patients with essential thrombocythemia: iwg-mrt (ipset model; passamonti et al, blood 2012) prognostic score is a good predictor of survival 123
Core binding factor acute myeloid leukemia and c-kit mutations 119
Anaplastic lymphoma kinase in human cancer 115
The enzymatic activity of 5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase is enhanced by NPM-ALK: new insights in ALK-mediated pathogenesis and the treatment of ALCL 112
The thymidylate synthase inhibitor ZD1604 potently inhibits murine and human cytomegalovirus replication in quiescent fibroblasts 102
Bone Marrow Wilms Tumor Gene 1 Expression before Allogeneic Hematopoietic Cell Transplantation Correlates with Relapse in Acute Myeloid Leukemia Patients. 99
Involvement of Grb2 adaptor protein in nucleophosmin-anaplastic lymphoma kinase (NPM-ALK)-mediated signaling and anaplastic large cell lymphoma growth. 99
The antiproliferative activity of the murine interferon-inducible Ifi 200 proteins depends on the presence of two 200 amino acid domains. 95
Human cytomegalovirus stimulates cellular dihydrofolate reductase activity in quiescent cells. 94
Prognostic value of JAK2V617F, CALR and MPL mutational status on outcome and thrombotic risk in a retrospective cohort of 138 patients with Essential THrombocythemia 94
Control of murine cytomegalovirus replication in salivary glands during acute infection is independent of the Fas ligand/Fas system. 92
Myelodysplastic syndrome with isolated del (5q) and JAK2V617F mutation transformed into an acute myeloid leukemia. 88
Expression of an altered ribonucleotide reductase activity associated with the replication of murine cytomegalovirus in quiescent fibroblasts 87
Minimal residual disease in acute myeloid leukemia detected by Wilms tumor gene 1 expression and multiparameter flow cytometry. 87
JAK2V617F mutation and allele burden: correlation with morphologic and clinical features and response to therapy in patients with essential thrombocytemia. 85
Interleukin-8 induces the accumulation of B-cell chronic lymphocytic leukemia cells by prolonging survival in an autocrine fashion 83
ALK-dependent control of hypoxia-inducible factors mediates tumor growth and metastasis 83
Murine cytomegalovirus stimulates cellular thymidylate synthase gene expression in quiescent cells and requires the enzyme for replication. 82
Human lung carcinoma cells engineered to release IL2, IL7, GM-CSF and TNF alpha 82
WT1 Expression in acute myeloid leukaemia:a useful marker for improving therapy response evaluation. 82
Stat3 is required for anchorage-independent growth and metastasis but not for mammary tumor development downstream of the ErbB-2 oncogene 80
In vitro and in vivo expression analysis of the Interferon-inducible 203 gene. 77
The anticytomegaloviral activity of raltitrexed is abrogated in quiescent mouse fibroblasts that overexpress thymidylate synthase 77
Molecular cloning and expression of a novel Interferon-inducible protein encoded by a 203 gene from the 200 cluster. 76
Evidence that the Human Cytomegalovirus 46 kDa UL72 protein is not an active dUTPase but a late protein dispensable for replication in fibroblasts 76
Chronic myeloid leukemia cells resistant to interferon-alpha lack STAT1 expression. 76
JAK2 V617F activating mutation in chronic myelomonocytic leukemia 76
Unveiling the pathogenetic role of Stat3 in human lymphoma 76
Post-Remissional And Pre-Transplant Role Of MRD Detected By WT1 In Acute Myeloid Leukemia: A Retrospective Cohort Study. 74
NPM-ALK oncogenic tyrosine kinase controls T-cell identity by transcriptional regulation and epigenetic silencing in lymphoma cells 73
JAK2V617F MUTATIONAL STATUS IS ASSOCIATED WITH DIFFERENT PHENOTYPES IN ESSENTIAL TROMBOCYTHEMIA 66
Murine cytomegalovirus replication in salivary glands is controlled by both perforin and granzymes during acute infection. 66
Overexpression of cellular thymidylate synthase inhibits the anti-cytomegaloviral activity of ZD1694 in quiescent murine fibroblasts 64
Human cytomegalovirus infection induces cellular thymidylate synthase gene expression in quiescent fibroblasts. 64
JAK2V617F, CALR and MPL mutations and bone marrow histology in patients with essential thrombocythemia. 62
Survival improvement of poor-prognosis AML/MDS patients by maintenance treatment with low-dose chemotherapy and differentiating agents. 61
JAK2V617F mutation and allele burden in patients with essential thrombocythemia 60
Human cytomegalovirus requires cellular deoxycytidylate deaminase for replication in quiescent cells. 60
The ENDOPREDICT® molecular test for breast cancer prognosis: clinical-pathological correlations and therapeutic implications on a selected cohort of patients 57
Real time quantitative detection of WT1 gene transcript in acute myeloid leukemia 42
Transfer of the interleukin-2 gene into human cancer cells induces specific antitumor recognition and restores the expression of CD3/T-cell receptor associated signal transduction molecules. 37
First-hit SETBP1 mutations cause a myeloproliferative disorder with bone marrow fibrosis 4
Totale 6.105
Categoria #
all - tutte 15.087
article - articoli 0
book - libri 0
conference - conferenze 4.386
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 19.473


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.239 0 0 167 126 219 214 110 69 103 93 64 74
2020/2021613 63 32 44 30 57 34 51 23 85 35 80 79
2021/2022624 47 41 27 51 15 23 44 32 26 40 145 133
2022/2023969 88 86 22 101 101 254 58 57 91 29 53 29
2023/2024405 59 72 26 22 18 63 16 15 2 41 23 48
2024/202586 15 71 0 0 0 0 0 0 0 0 0 0
Totale 6.105